Federal Activity

Patient choice and healthcare equality must become a top priority of our nation’s policymakers. One of the most effective means of influencing policymakers is the collective voice of the ATA membership. When Members of Congress hear directly from you, it is highly impactful and makes a powerful statement. This may influence their policy position or even the details of legislation.

Who is the best advocate for telehealth? ATA members.

Learn more about your legislators, the bills affecting telehealth that are moving through Congress, and how you can to take action. Members of Congress listen to their constituents, particularly those from their home states and districts and those who are knowledgeable of the area they are advocating. Whether it is writing letters in support of legislation, keeping track of bills in Congress, or making a statement on social media, we are here to help.

Explore federal level advocacy opportunities

ATA Comments on Proposed Stark Law and Anti-Kickback Statute Reforms

The ATA shared feedback with the U.S. Department of Health and Human Services on the agency’s proposed changes to the regulations that interpret the Physician Self-Referral Law (the “Stark Law”) and the Federal Anti-Kickback Statute.

more information
ATA Response to Cures 2.0 Call to Action
"Cures 2.0" Legislative Framework

The ATA shared feedback with leaders in Congress as work begins on a framework for a “Cures 2.0” legislative package that would build and expand on reforms included in the 21st Century Cures Act, passed in December 2016.

more information
Stakeholder Letter to DEA on Ryan Haight Special Registration
H.R. 6353

ATA, along with a number of healthcare stakeholders, submitted a letter with comments on the Drug Enforcement Administration’s (DEA) implementation of a Special Registration provision for telemedicine under the Ryan Haight Act.

more information
ATA Response to HHS RFI: Ensuring Patient Access and Effective Drug Enforcement
Public Law 114-145

ATA commends the Office of the Assistant Secretary for Planning and Evaluation for seeking input on how to ensure legitimate access to controlled substances while also preventing diversion and abuse. This issue is very important to our members and we appreciate being able to provide feedback and recommendations.

more information
H.R. 6502

The ATA supports legislative efforts to expand access to telehealth services, which we believe will improve patient outcomes, patients and provider satisfaction, and lower costs to the healthcare system. The RUSH Act, introduced in the 115th Congress, represents one such effort by expanding access to emergency telehealth for Medicare patients in nursing homes with the goal of reducing unnecessary emergency room visits and hospitalizations.

more information
Special Registration Process for Telehealth under the Ryan Haight Act
H.R. 6353

In response to the mandate from H.R. 6, the ATA convened a special member workgroup within its Telebehavioral Health Special Interest Group. The workgroup developed five recommendations for how a special registration process could be structured to enable the safe prescribing of certain controlled substances via telehealth.

more information

Guiding Principles for Federal Policy Priorities

  • Eliminate artificial government barriers to telehealth, such as geographic discrimination and restrictions on the use of telehealth in managed care;
  • Encourage use of telehealth to reduce health delivery problems, such as provider shortages;
  • Prevent new barriers to telehealth, such as clinical practice rules that impose higher standards for telehealth-provided services than in-person care;
  • Promote payment and service delivery models to increase consumer and payer value using telemedicine and
  • Enhance patient choice, outcomes, convenience, and satisfaction

ATA 2017 Policy Priorities


Watch ATA Members Champion Telehealth Initiatives.

The University of Maryland Medical Center (UMMC) and HealthLink Now testified before the House Small Business Committee

The University of Virginia testified before the Senate Committee on Commerce, and Transportation